drugset / Trial / NCT02107391
Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether DCVAC/PCa added onto hormone therapy can improve PSA progression times for patients with Metastatic Prostate Cancer.
Timeline
- Start
- 2012-03
- Primary completion
- 2015-12
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Goserelin | Other / unclassified | — | — |
| Comparator | Leuprolide | Other / unclassified | — | — |
| Subject | STAPULDENCEL | Vaccine | — | — |